NCT07153029

Brief Summary

The increasing prevalence of opioid use disorder (OUD) among older adults, coupled with high overdose rates and cognitive impairments associated with opioid use, highlights a critical gap in addiction treatment. Cognitive impairments can persist despite treatment and negatively impact recovery outcomes, yet cognitive screening and interventions are rarely integrated into OUD care. This study aims to evaluate the feasibility of remotely delivered, smartphone-based cognitive assessments (administered through NeuroUX web-based software) for older adults (55+) in methadone treatment. The tasks have been "gamified" to make them engaging and brief, which could be appealing to patients. They will complete the tasks for 15 days using the phone provided or their own phone. During days 6-15 of testing, tasks will become incrementally more difficult based on participant performance to assess the feasibility of cognitive training. Cognitive training uses engaging games or tasks to strengthen thinking skills like memory and focus, much like physical exercise strengthens the body. Adherence, acceptability, and usability of the tasks will be assessed. Secondary analyses will explore relationships between task performance and participant characteristics (e.g., baseline cognitive functioning, methadone dose, timing of methadone dose). Findings from this pilot study will provide foundational data for a future grant application to develop and test digital cognitive assessment and training interventions tailored to older adults in addiction treatment. By addressing a critical yet understudied aspect of OUD care this research has the potential to enhance treatment engagement, improve clinical outcomes, and support long-term recovery in the growing older population.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
9mo left

Started Dec 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress38%
Dec 2025Jan 2027

First Submitted

Initial submission to the registry

August 25, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 3, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

December 3, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2027

Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

11 months

First QC Date

August 25, 2025

Last Update Submit

February 25, 2026

Conditions

Keywords

older adultscognitionfeasibilityecological momentary assessment

Outcome Measures

Primary Outcomes (4)

  • Adherence to smartphone task completion

    proportion of completed assessments on the smartphone

    across 15 days of use

  • Satisfaction with smartphone tasks

    Proportion reporting high satisfaction (\>70%) with smartphone tasks

    across 15 days of use

  • Usability of smartphone tasks

    mean score \> 68 on the "System Usability Scale" a reliable, low-cost usability scale that can be used for global assessments of systems usability. Higher scores indicate greater usability.

    after 15 days of use

  • Cognitive Task Performance

    Performance on each of 3 cognitive tasks will be assessed for each time a task is completed. Performance will be compared across days of use.

    15 days of smartphone tasks

Secondary Outcomes (1)

  • Laboratory cognitive functioning

    1 month (pre-post 15 day cognitive tasks on smartphone)

Other Outcomes (1)

  • Montreal Cognitive Asesssment (MOCA) (baseline cognitive performance)

    Baseline assessment (before 15 days of smartphone task completion)

Study Arms (1)

Smartphone-based assessments and cognitive tasks

EXPERIMENTAL

All participants will complete a baseline session to colelct data related to demographics, health history/status, and cognitive functioning. Participants will be oriented to the smartphone application which is delivered via NeuroUX cloud-based technology which send a text message to the smartphone as a prompt for tasks which will be administered across 15 days. All participants complete the same tasks and duration of tasks. Then all participants complete a follow-up assessment to examine their preferences related to the smartphone and cognitive function.

Behavioral: Smartphone based cognitive tasks

Interventions

15 days Smartphone/Cellphone tasks: Using NeuroUX smartphone testing software, Cognitive "games"/tasks lasting approximately 3-4 minutes each will be administered through the a smartphone application and will be prompted via text message twice per day across 15 consecutive days in the morning (8-11am) and evening (5-8). Tasks were chosen to measure aspects of diverse aspects of cognitive that are impaired among patients taking methadone, including N-back task (working memory), the Stroop Task (executive function/cognitive control), and the Variable Difficulty List Memory Test (learning and memory). The 15 days will include two types of task administration: a) Testing Phase: tasks administered at a consistent, fixed difficulty level (days 1-5) b) Remediation Phase: increasing task difficulty in response to participant performance (days 6-15). To encourage adherence, researchers will contact participants to remind them of task completion.

Smartphone-based assessments and cognitive tasks

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 55 and older
  • currently in outpatient methadone treatment for opioid use disorder
  • participant is alert/able to communicate/able to give acceptable answers on the "Evaluation to Sign Consent form
  • participant has normal or correct to normal vision

You may not qualify if:

  • age 54 or younger
  • not in methadone treatment for opioid use disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UM Addiction Treatment Programs at 1001 West Pratt

Baltimore, Maryland, 21124, United States

Location

MeSH Terms

Conditions

Opioid-Related Disorders

Condition Hierarchy (Ancestors)

Narcotic-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: This study is a prospective feasibility trial evaluating the use of brief, daily, remotely delivered cognitive assessments over 15 consecutive days among patients aged 55 years and older receiving methadone treatment for opioid use disorder (OUD).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Psychiatry, University of Maryland School of Medicine

Study Record Dates

First Submitted

August 25, 2025

First Posted

September 3, 2025

Study Start

December 3, 2025

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

January 15, 2027

Last Updated

February 27, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

De-identified individual participant data, including baseline characteristics and outcome measures, will be shared with qualified researchers upon request. Data will be available after publication of the primary results. Requests will require approval by the principal investigator.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Start date: date when study is completed and data analyses are completed End date: 5 years from date of study completion and data analyses completed
Access Criteria
Request sent to Principal Investiagator and approved by Principal Investigator

Locations